Given the functional specificities of cDC1, strategies aimed at their mobilization to the tumor microenvironment, as well as their expansion and activation, are viewed as highly promising approaches for boosting anti-tumor immunity and improving the success of cancer immunotherapies (Table 1). Here, MPPE1 is linked to neoplasm.